Searle & Co’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$51K | – | 158 |
|
|
2022
Q1 | $51K | Hold |
20,000
| – | – | 0.02% | 152 |
|
|
2021
Q4 | $59K | Hold |
20,000
| – | – | 0.02% | 156 |
|
|
2021
Q3 | $49K | Buy |
+20,000
| New | +$49K | 0.02% | 144 |
|
|
2021
Q2 | – | Sell |
-21,500
| Closed | -$97K | – | 151 |
|
|
2021
Q1 | $97K | Sell |
21,500
-12,500
| -37% | -$56.4K | 0.04% | 137 |
|
|
2020
Q4 | $167K | Buy |
+34,000
| New | +$167K | 0.08% | 134 |
|
|
2020
Q3 | – | Sell |
-69,000
| Closed | -$148K | – | 146 |
|
|
2020
Q2 | $148K | Buy |
69,000
+17,000
| +33% | +$36.5K | 0.09% | 128 |
|
|
2020
Q1 | $101K | Buy |
+52,000
| New | +$101K | 0.07% | 120 |
|